Westford, USA, June 18, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the cancer gene therapy market will attain a value of USD 12.63 billion by 2031, with a CAGR of 20.42% during the forecast period (2024-2031). Evolution in genetic research and therapeutic approaches have fostered a powerful growth in the cancer gene therapy market. Gene therapies enable targeted interventions at the genetic level, presenting a huge potential in cancer treatments. Hence, this market encounters severe push from the upward trajectory of global cancer incidence and growing demand for personalized medicine, to use gene therapy as a promising treatment path for cancer patients. On top of that, intensive research and development activities, positive governmental policies, and research institutions in collaboration with pharmaceutical firms have worked out to further expand the market. 

First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter

Westford, USA, June 18, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Carbon Capture, Utilization and Storage Market will attain a value of USD 6.16 billion by 2031, with a CAGR of 11.8% during the forecast period (2024-2031). Carbon capture and storage or CCS is a relatively new technology, that has come forward due to increasing awareness related to the growing   environmental impact of carbon emissions. It can minimize CO2 emissions significantly as well as help us to meet demanding climate goals. As a result, it is promoted by governments through several demonstration projects in different industries around the world. CCS is being viewed as a critical technology which can help us in wide-scale adoption of renewable energy sources such as wind and solar, without which fossil fuels will continue to dominate energy generation and consumption patterns. 

                                                        FORM 8.3

Seasoned turnaround advisor and corporate attorney brings over 25 years leadership experience in the public markets

WARREN, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced its expected addition to the broad-market Russell 3000^® and Russell 2000^® Indexes at the conclusion of the 2024 Russell U.S. indexes annual reconstitution, effective at the open of U.S. equity markets on Monday, July 1, according to a preliminary list of additions posted Friday, May 24, 2024.

VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) -- Prosper Gold Corp. ("Prosper Gold" or the "Company") (TSXV:PGX) is pleased to announce that crews and equipment have been mobilized to initiate a property-wide ZTEM geophysical survey at the Company’s Cyprus Project in north-central British Columbia, Canada. The Cyprus Project is a district-scale porphyry copper-gold project with several historically defined copper ± gold porphyry prospects and significant drill results including 138.2 metres at 0.55% copper.

Expands reach of authID’s next-gen biometric identity platform with integration to Syntrove’s risk and fraud technology platform

SAN FRANCISCO, June 18, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced it will host the second part of its virtual KOL investor event series on Wednesday, June 26, 2024 at 10:00 AM ET. To register, click here.

New analysis of the pivotal Phase 3 SOLOIST-WHF trial demonstrates INPEFA cost-effectiveness

MALVERN, Pa., June 18, 2024 (GLOBE NEWSWIRE) -- via IBN -- Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (AD) and Parkinson’s disease (PD), is pleased to announce that it has been selected to present the data from its latest Alzheimer’s study in an extended 45-minute session at the Alzheimer’s Association International Conference® 2024 (AAIC®). The conference will take place from July 28 to August 1 in Philadelphia, USA, and online.

– Phase 1b study will evaluate safety, pharmacokinetic and efficacy endpoints in participants with chronic hepatitis B virus infection with interim data expected by the end of 2024 –

SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a fireside chat at the H.C. Wainwright 2^nd Annual Immune Cell Engager Virtual Conference on Tuesday, June 25, 2024, at 2:00 p.m. ET.

CHICAGO, June 18, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced the company will present at the Noble Capital Markets Consumer, Communications, Media, and Technology Emerging Growth Virtual Equity Conference on Wednesday, June 26, 2024, at 2:00 p.m. Eastern Time.

For the second year in a row, Kaltura has won for every category in which it was nominated

In the news release, “Apollo Tactical Income Fund Inc. Declares June 2024 Monthly Distribution of $0.144 Per Share,” issued 11-Jun-2024 by Apollo Tactical Income Fund Inc. over GlobeNewswire, we are advised by the Fund that the third paragraph, first sentence reading “Ex-Date,” should read “June 21, 2024” rather than “June 20, 2024” as originally issued inadvertently. The complete, corrected release follows:

North Reading, MA, June 18, 2024 (GLOBE NEWSWIRE) -- Powerdyne International, Inc. (Ticker: PWDY) announces the Company has begun preliminary talks with an AI motor manufacturer for a potential acquisition or merger.

LONGUEUIL, Québec, June 18, 2024 (GLOBE NEWSWIRE) -- Reunion Gold Corporation (TSXV: RGD; OTCQX: RGDFF) (the “Company” or “Reunion Gold”) wishes to remind holders of outstanding common share purchase warrants issued on July 8, 2022 (the “Warrants”) that the Warrants will expire at 4:00 p.m. Vancouver time on Monday, July 8, 2024.